rs745340459

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_001023570.4(IQCB1):​c.897_900dupCTTG​(p.Ile301LeufsTer42) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000659 in 151,724 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00014 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

IQCB1
NM_001023570.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:9

Conservation

PhyloP100: 0.884

Publications

3 publications found
Variant links:
Genes affected
IQCB1 (HGNC:28949): (IQ motif containing B1) This gene encodes a nephrocystin protein that interacts with calmodulin and the retinitis pigmentosa GTPase regulator protein. The encoded protein has a central coiled-coil region and two calmodulin-binding IQ domains. It is localized to the primary cilia of renal epithelial cells and connecting cilia of photoreceptor cells. The protein is thought to play a role in ciliary function. Defects in this gene result in Senior-Loken syndrome type 5. Alternative splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 6. [provided by RefSeq, Jan 2016]
IQCB1 Gene-Disease associations (from GenCC):
  • Senior-Loken syndrome 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Leber congenital amaurosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 3-121795542-T-TCAAG is Pathogenic according to our data. Variant chr3-121795542-T-TCAAG is described in ClinVar as [Pathogenic]. Clinvar id is 403963.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IQCB1NM_001023570.4 linkc.897_900dupCTTG p.Ile301LeufsTer42 frameshift_variant Exon 10 of 15 ENST00000310864.11 NP_001018864.2 Q15051-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IQCB1ENST00000310864.11 linkc.897_900dupCTTG p.Ile301LeufsTer42 frameshift_variant Exon 10 of 15 1 NM_001023570.4 ENSP00000311505.6 Q15051-1
IQCB1ENST00000349820.10 linkc.588-5331_588-5328dupCTTG intron_variant Intron 7 of 11 1 ENSP00000323756.7 Q15051-2
IQCB1ENST00000460108.5 linkc.345_348dupCTTG p.Ile117LeufsTer28 frameshift_variant Exon 9 of 9 5 ENSP00000419168.1 C9JXD7
IQCB1ENST00000393650.7 linkn.876+1572_876+1575dupCTTG intron_variant Intron 9 of 13 5 ENSP00000377261.3 Q15051-3

Frequencies

GnomAD3 genomes
AF:
0.0000659
AC:
10
AN:
151724
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000726
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000558
AC:
14
AN:
250990
AF XY:
0.0000442
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000144
AC:
208
AN:
1449106
Hom.:
0
Cov.:
28
AF XY:
0.000143
AC XY:
103
AN XY:
721910
show subpopulations
African (AFR)
AF:
0.0000301
AC:
1
AN:
33238
American (AMR)
AF:
0.00
AC:
0
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26032
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39604
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85980
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53404
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5596
European-Non Finnish (NFE)
AF:
0.000184
AC:
203
AN:
1100564
Other (OTH)
AF:
0.0000667
AC:
4
AN:
59988
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000659
AC:
10
AN:
151724
Hom.:
0
Cov.:
31
AF XY:
0.0000675
AC XY:
5
AN XY:
74098
show subpopulations
African (AFR)
AF:
0.0000726
AC:
3
AN:
41304
American (AMR)
AF:
0.00
AC:
0
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10538
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
67890
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000174
Hom.:
0
Bravo
AF:
0.0000982

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Senior-Loken syndrome 5 Pathogenic:4
Oct 31, 2019
Revvity Omics, Revvity
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 12, 2024
Baylor Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 01, 2016
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 18, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephronophthisis Pathogenic:2
Sep 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Ile301Leufs*42) in the IQCB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IQCB1 are known to be pathogenic (PMID: 15723066, 21901789, 23559409, 28041643). This variant is present in population databases (rs745340459, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with nephronophthisis-related ciliopathies, including Senior-Loken syndrome (PMID: 23188109, 23559409, 26673778). ClinVar contains an entry for this variant (Variation ID: 403963). For these reasons, this variant has been classified as Pathogenic. -

Mar 02, 2018
Sydney Genome Diagnostics, Children's Hospital Westmead
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

This patient is heterozygous for the c.758del variant in the IQCB1 gene. This frameshifting variant is predicted to create a premature stop codon p.(Cys253Serfs*9) and may result in a null allele due to nonsense-mediated mRNA decay. This variant has been listed in the ExAC database (http://exac.broadinstitute.org) with a very low allele frequency of 0.001% (1 out of 118,070 alleles). The c.758del variant has been reported in a compound heterozygous state with another truncating variant in a patient with Senior-Loken syndrome (Halbritter et al. 2012 J Med Genet 49:756-767). This variant is considered to be likely pathogenic according to the ACMG guidelines. -

not provided Pathogenic:2
Sep 16, 2018
Gharavi Laboratory, Columbia University
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Sep 18, 2024
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31964843, 26673778, 35409265, 38219857, 38522724, 29974258, 23559409, 23188109, 30586318) -

Retinal dystrophy Pathogenic:1
Sep 28, 2017
Blueprint Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.88
Mutation Taster
=2/198
disease causing (ClinVar)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs745340459; hg19: chr3-121514389; API